Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Les I, Martínez M, Pérez-Francisco I, Cabero M, Teijeira L, Arrazubi V, Torrego N, Campillo-Calatayud A, Elejalde I, Kochan G, Escors D. Les I, et al. Among authors: elejalde i. Cancers (Basel). 2023 Mar 6;15(5):1629. doi: 10.3390/cancers15051629. Cancers (Basel). 2023. PMID: 36900420 Free PMC article. Review.
Methylprednisolone Pulses in Hospitalized COVID-19 Patients Without Respiratory Failure: A Randomized Controlled Trial.
Les I, Loureiro-Amigo J, Capdevila F, Oriol I, Elejalde I, Aranda-Lobo J, Modesto J, Güell-Farré E, García R, Murgadella-Sancho A, Anniccherico J, Martín-Fernández M, Lorza JJ, Monteys-Montblanch JP, Librero J, Pintado-Lalueza S, Delgado M, Gracia-García B, Sánchez-Álvarez J, Pestaña-Fernández M, Fanlo P, Funalleras-Puig G, Sarobe M, Mediavilla E, Ibero C. Les I, et al. Among authors: elejalde i. Front Med (Lausanne). 2022 Feb 28;9:807981. doi: 10.3389/fmed.2022.807981. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35295605 Free PMC article.
Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study.
Les I, Pérez-Francisco I, Cabero M, Sánchez C, Hidalgo M, Teijeira L, Arrazubi V, Domínguez S, Anaut P, Eguiluz S, Elejalde I, Herrera A, Martínez M. Les I, et al. Among authors: elejalde i. Front Pharmacol. 2022 Jun 1;13:894550. doi: 10.3389/fphar.2022.894550. eCollection 2022. Front Pharmacol. 2022. PMID: 35721217 Free PMC article.
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective.
Teijeira L, Martínez M, Moreno A, de Elejoste I, Ibáñez-Beroiz B, Arrazubi V, Díaz de Corcuera I, Elejalde I, Campillo-Calatayud A, Les I. Teijeira L, et al. Among authors: elejalde i. Cancers (Basel). 2023 Dec 28;16(1):151. doi: 10.3390/cancers16010151. Cancers (Basel). 2023. PMID: 38201577 Free PMC article.